BMJ Magazine in August 2025 has a new study showing that Ambien, Lunesta, and other sleeping pills increase Alzheimer’s risk 81% after just 3 months. One in four seniors are now prescribed sleeping pills. URMC’s January 2025 study revealed how these meds suppress the brain’s glymphatic system that clears Alzheimer’s-linked plaque. The Alzheimer’s Society’s November 2024 AAC conference report linked sleeping pills to 79% higher falls in patients, urging a stop to the prescribing of these drugs.
“Sleeping Pills Causing Alzheimer’s”
These statement have not been evaluated by the Food and Drug Administration. Products or services at Gilead Balm are not intended to diagnose, treat, cure, or prevent any disease.